Belinostat (PXD101) Catalog No.:M22445-C 3Z)-3-(hydroxyimino)-2'-oxo-1'

3Z)-3-(hydroxyimino)-2'-oxo-1'

[O-]S(=O)(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO

3R)-2-[(Z)-[(2S

and a variety of other symptoms in cattle

PubMed PMID: 31773093

Belinostat (PXD101) Catalog No.:M22445-C 3Z)-3-(hydroxyimino)-2'-oxo-1'Belinostat (also known as PXD101) is a novel and potent hydroxamate type inhibitor of histone deacetylase (HDAC) that inhibits the activity of HDAC in Hela cell extracts with 50% inhibition concentration IC50 value of 27 nM. Belinostat has been found to significantly increase the acetylation of histones H3 and H4 and exerts cytotoxicity in a wide range of tumor cell lines. In the treatment of urothelial carcinoma cell lines, belinostat dose